Smartleaf Asset Management LLC Pacira Bio Sciences, Inc. Transaction History
Smartleaf Asset Management LLC
- $981 Billion
- Q4 2024
A detailed history of Smartleaf Asset Management LLC transactions in Pacira Bio Sciences, Inc. stock. As of the latest transaction made, Smartleaf Asset Management LLC holds 425 shares of PCRX stock, worth $10,259. This represents 0.0% of its overall portfolio holdings.
Number of Shares
425
Previous 31
1270.97%
Holding current value
$10,259
Previous $450,000
1688.67%
% of portfolio
0.0%
Previous 0.0%
Shares
3 transactions
Others Institutions Holding PCRX
# of Institutions
260Shares Held
49.8MCall Options Held
1.03MPut Options Held
139K-
Black Rock Inc. New York, NY8.01MShares$193 Million0.01% of portfolio
-
Vanguard Group Inc Valley Forge, PA5.26MShares$127 Million0.0% of portfolio
-
Pacer Advisors, Inc. Malvern, PA3.26MShares$78.8 Million0.15% of portfolio
-
D. E. Shaw & Co., Inc. New York, NY2.26MShares$54.5 Million0.03% of portfolio
-
Jim Simons Renaissance Technologies LLC | New York, Ny1.99MShares$48.1 Million0.06% of portfolio
About Pacira BioSciences, Inc.
- Ticker PCRX
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 45,824,200
- Market Cap $1.11B
- Description
- Pacira BioSciences, Inc. provides non-opioid pain management and regenerative health solutions for healthcare practitioners and their patients in the United States. The company offers EXPAREL, a bupivacaine liposome injectable suspension; ZILRETTA, a triamcinolone acetonide extended-release injectable suspension; and iovera system, a non-opioid ...